These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38478961)

  • 1. Analysis of drug-induced posterior reversible encephalopathy syndrome using the food and drug administration adverse drug events reporting system database.
    Lei CL; Gui XL; Wang LY; Guo YJ; Li Y
    Expert Opin Drug Saf; 2024 May; 23(5):607-616. PubMed ID: 38478961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
    Welch HK; Kellum JA; Kane-Gill SL
    Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced progressive multifocal leukoencephalopathy: a case/noncase study in the French pharmacovigilance database.
    Colin O; Favrelière S; Quillet A; Neau JP; Houeto JL; Lafay-Chebassier C; Pérault-Pochat MC;
    Fundam Clin Pharmacol; 2017 Apr; 31(2):237-244. PubMed ID: 27736027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rising cases of drug-induced pulmonary fibrosis: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database, 2000-2022.
    McCall KL; Hennig KR; Abe ZT; Dattler DN; Hurd KL; Portnoy SL; Zagoria ZJ
    Pharmacoepidemiol Drug Saf; 2024 May; 33(5):e5797. PubMed ID: 38680101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of daratumumab in the real-world: a pharmacovigilance study based on FAERS database.
    Wu J; Wu H; Chen L; Liang H; Huang G; Yang S; Chen B; Noguchi Y; Shen Y
    Expert Opin Drug Saf; 2024 Jul; 23(7):905-916. PubMed ID: 38108285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacovigilance study on drug-induced liver injury associated with antibody-drug conjugates (ADCs) based on the food and drug administration adverse event reporting system.
    Sun C; Yang X; Tang L; Chen J
    Expert Opin Drug Saf; 2024 Aug; 23(8):1049-1060. PubMed ID: 37898875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Disproportionality Analysis to Identify Previously Unknown Drug-Associated Causes of Cardiac Arrhythmias Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
    Moreland-Head LN; Coons JC; Seybert AL; Gray MP; Kane-Gill SL
    J Cardiovasc Pharmacol Ther; 2021 Jul; 26(4):341-348. PubMed ID: 33403858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Data mining and safety analysis of avatrombopag: a retrospective pharmacovigilance study based on the US food and drug administration's adverse event reporting system.
    Zhu H; Wu M
    Sci Rep; 2024 May; 14(1):11262. PubMed ID: 38760419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced Sweet's syndrome: A case/non-case study in the French pharmacovigilance database.
    Martin S; Trenque T; Herlem E; Boulay C; Pizzoglio V; Azzouz B
    Br J Clin Pharmacol; 2024 Aug; 90(8):1873-1879. PubMed ID: 37555568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of non-steroidal anti-inflammatory drug use with encephalopathy development: An analysis using the United States Food and Drug Administration Adverse Event Reporting System (FAERS) and Japanese Adverse Drug Event Report (JADER) databases.
    Kawada K; Ishida T; Yoshioka T; Fukuda H; Hayashi T; Goda M; Ishizawa K
    Pharmazie; 2024 Jun; 79(6):118-123. PubMed ID: 38877682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib.
    Peng L; Xiao K; Ottaviani S; Stebbing J; Wang YJ
    Expert Opin Drug Saf; 2020 Nov; 19(11):1505-1511. PubMed ID: 32693646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
    Patel NM; Stottlemyer BA; Gray MP; Boyce RD; Kane-Gill SL
    Cardiovasc Drugs Ther; 2022 Apr; 36(2):309-322. PubMed ID: 33599896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A real‑world pharmacovigilance study of FDA adverse event reporting system events for daratumumab.
    Yun X; Zhou Y; Wu D; Liu Y; Wu Q
    Expert Opin Drug Saf; 2024 May; 23(5):581-591. PubMed ID: 38600747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in adverse events related to Osimertinib: a real-world pharmacovigilance analysis of FDA adverse event reporting system.
    Li Z; Zou W; Yuan J; Zhong Y; Fu Z
    Expert Opin Drug Saf; 2024 Jun; 23(6):763-770. PubMed ID: 37515501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
    Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
    Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Hyponatraemia and Antidepressant Drugs: A Pharmacovigilance-Pharmacodynamic Assessment Through an Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
    Mazhar F; Pozzi M; Gentili M; Scatigna M; Clementi E; Radice S; Carnovale C
    CNS Drugs; 2019 Jun; 33(6):581-592. PubMed ID: 30977109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced hypoglycemia: a disproportionality analysis of the FAERS database.
    Li J; Wang Y; Yang X; Zhu H; Jiang Z
    Expert Opin Drug Saf; 2024 Aug; 23(8):1061-1067. PubMed ID: 37909653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose: An analysis of the Food And Drug Administration Adverse Events Reporting System (FAERS).
    Evoy KE; Covvey JR; Peckham AM; Ochs L; Hultgren KE
    Res Social Adm Pharm; 2019 Aug; 15(8):953-958. PubMed ID: 31303196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems.
    Raschi E; Parisotto M; Forcesi E; La Placa M; Marchesini G; De Ponti F; Poluzzi E
    Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1098-1107. PubMed ID: 29174026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A real-world pharmacovigilance study of amivantamab-related cardiovascular adverse events based on the FDA adverse event reporting system (FAERS) database.
    Sun R; Ning Z; Qin H; Zhang W; Teng Y; Jin C; Liu J; Wang A
    Sci Rep; 2024 Apr; 14(1):9552. PubMed ID: 38664423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.